CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Treasury Shares | Paid-In Capital | Accumulated Other Comprehensive Income | Retained Earnings |
Beginning balance (in shares) at Dec. 31, 2020 | | 478,000,000 | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | 79,000,000 | | | |
Balance at beginning of period at Dec. 31, 2020 | $ 2,216 | $ 48 | $ (1,823) | $ 1,804 | $ 2 | $ 2,185 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 126 | | | | | 126 |
Stock amortization and vesting | 4 | | | 4 | | |
Common stock cash dividends | (40) | | | | | (40) |
Ending balance (in shares) at Mar. 31, 2021 | | 478,000,000 | | | | |
Ending balance (in shares) at Mar. 31, 2021 | | | 79,000,000 | | | |
Balance at end of period at Mar. 31, 2021 | 2,306 | $ 48 | $ (1,823) | 1,808 | 2 | 2,271 |
Beginning balance (in shares) at Dec. 31, 2020 | | 478,000,000 | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | 79,000,000 | | | |
Balance at beginning of period at Dec. 31, 2020 | 2,216 | $ 48 | $ (1,823) | 1,804 | 2 | 2,185 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 220 | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | 478,000,000 | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | 79,000,000 | | | |
Balance at end of period at Sep. 30, 2021 | 2,327 | $ 48 | $ (1,823) | 1,823 | 2 | 2,277 |
Beginning balance (in shares) at Mar. 31, 2021 | | 478,000,000 | | | | |
Beginning balance (in shares) at Mar. 31, 2021 | | | 79,000,000 | | | |
Balance at beginning of period at Mar. 31, 2021 | 2,306 | $ 48 | $ (1,823) | 1,808 | 2 | 2,271 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 30 | | | | | 30 |
Stock amortization and vesting | 8 | | | 8 | | |
Common stock cash dividends | (44) | | | | | (44) |
Ending balance (in shares) at Jun. 30, 2021 | | 478,000,000 | | | | |
Ending balance (in shares) at Jun. 30, 2021 | | | 79,000,000 | | | |
Balance at end of period at Jun. 30, 2021 | 2,300 | $ 48 | $ (1,823) | 1,816 | 2 | 2,257 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 64 | | | | | 64 |
Stock amortization and vesting | 7 | | | 7 | | |
Common stock cash dividends | (44) | | | | | (44) |
Ending balance (in shares) at Sep. 30, 2021 | | 478,000,000 | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | 79,000,000 | | | |
Balance at end of period at Sep. 30, 2021 | $ 2,327 | $ 48 | $ (1,823) | 1,823 | 2 | 2,277 |
Beginning balance (in shares) at Dec. 31, 2021 | | 893,000,000 | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | 79,082,385 | | 79,000,000 | | | |
Balance at beginning of period at Dec. 31, 2021 | $ 11,738 | $ 89 | $ (1,826) | 10,911 | 1 | 2,563 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 608 | | | | | 608 |
Exercise of stock options | 6 | | | 6 | | |
Stock amortization and vesting | $ 10 | | | 10 | | |
Treasury stock repurchases (in shares) | 8,000,000 | | | | | |
Treasury stock repurchases | $ (192) | | | | | |
Common stock cash dividends | (455) | | | | | (455) |
Preferred stock cash dividends | (1) | | | | | (1) |
Other comprehensive income | 4 | | | | 4 | |
Ending balance (in shares) at Mar. 31, 2022 | | 893,000,000 | | | | |
Ending balance (in shares) at Mar. 31, 2022 | | | 87,000,000 | | | |
Balance at end of period at Mar. 31, 2022 | $ 11,718 | $ 89 | $ (2,018) | 10,927 | 5 | 2,715 |
Beginning balance (in shares) at Dec. 31, 2021 | | 893,000,000 | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | 79,082,385 | | 79,000,000 | | | |
Balance at beginning of period at Dec. 31, 2021 | $ 11,738 | $ 89 | $ (1,826) | 10,911 | 1 | 2,563 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | $ 3,033 | | | | | |
Treasury stock repurchases (in shares) | 28,000,000 | | | | | |
Treasury stock repurchases | $ (740) | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | 895,000,000 | | | | |
Ending balance (in shares) at Sep. 30, 2022 | 107,074,560 | | 107,000,000 | | | |
Balance at end of period at Sep. 30, 2022 | $ 12,659 | $ 90 | $ (2,566) | 10,992 | 6 | 4,137 |
Beginning balance (in shares) at Mar. 31, 2022 | | 893,000,000 | | | | |
Beginning balance (in shares) at Mar. 31, 2022 | | | 87,000,000 | | | |
Balance at beginning of period at Mar. 31, 2022 | 11,718 | $ 89 | $ (2,018) | 10,927 | 5 | 2,715 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 1,229 | | | | | 1,229 |
Exercise of stock options | 3 | | | 3 | | |
Stock amortization and vesting | 18 | | | 18 | | |
Conversion of Cimarex redeemable preferred stock (in shares) | | 1,000,000 | | | | |
Conversion of Cimarex redeemable preferred stock | 28 | | | 28 | | |
Treasury stock repurchases (in shares) | | | 12,000,000 | | | |
Treasury stock repurchases | (321) | | $ (321) | | | |
Common stock cash dividends | (484) | | | | | (484) |
Ending balance (in shares) at Jun. 30, 2022 | | 894,000,000 | | | | |
Ending balance (in shares) at Jun. 30, 2022 | | | 99,000,000 | | | |
Balance at end of period at Jun. 30, 2022 | 12,191 | $ 89 | $ (2,339) | 10,976 | 5 | 3,460 |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net income | 1,196 | | | | | 1,196 |
Exercise of stock options | 2 | | | 2 | | |
Stock amortization and vesting (in shares) | | 1,000,000 | | | | |
Stock amortization and vesting | 15 | $ 1 | | 14 | | |
Treasury stock repurchases (in shares) | | | 8,000,000 | | | |
Treasury stock repurchases | (227) | | $ (227) | | | |
Common stock cash dividends | (519) | | | | | (519) |
Other comprehensive income | $ 1 | | | | 1 | |
Ending balance (in shares) at Sep. 30, 2022 | | 895,000,000 | | | | |
Ending balance (in shares) at Sep. 30, 2022 | 107,074,560 | | 107,000,000 | | | |
Balance at end of period at Sep. 30, 2022 | $ 12,659 | $ 90 | $ (2,566) | $ 10,992 | $ 6 | $ 4,137 |